A Russian-backed hacking group is believed to have targeted organizations working on a coronavirus vaccine. CBS News foreign correspondent Charlie D'Agata reports from London, where the world's leading clinical trials might be at risk, and CBS News senior investigative correspondent Catherine Herridge joined CBSN to discuss.
